ZYXI – Zynex, Inc.
Float Short %
19.33
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
-1.45
EPS This/Next Y
0.88
Price
1.65
Target Price
4.57
Analyst Recom
2.33
Performance Q
-27.83
Relative Volume
0.51
Beta
1.05
Ticker: ZYXI
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-28 | ZYXI | 2.54 | 0.01 | 0.04 | 15179 |
| 2025-07-29 | ZYXI | 2.48 | 0.01 | 1.00 | 15287 |
| 2025-07-30 | ZYXI | 2.48 | 0.01 | 0.00 | 15289 |
| 2025-07-31 | ZYXI | 2.23 | 0.01 | 0.10 | 15408 |
| 2025-08-01 | ZYXI | 1.26 | 0.01 | 0.06 | 15412 |
| 2025-08-04 | ZYXI | 1.73 | 0.01 | 0.08 | 15558 |
| 2025-08-05 | ZYXI | 1.58 | 0.01 | 0.05 | 16315 |
| 2025-08-06 | ZYXI | 1.537 | 0.01 | 0.14 | 16191 |
| 2025-08-07 | ZYXI | 1.47 | 0.01 | 0.00 | 16191 |
| 2025-08-08 | ZYXI | 1.44 | 0.01 | 0.00 | 16190 |
| 2025-08-11 | ZYXI | 1.41 | 0.01 | 0.09 | 16645 |
| 2025-08-12 | ZYXI | 1.6 | 0.01 | 0.00 | 17203 |
| 2025-08-13 | ZYXI | 1.64 | 0.01 | 0.50 | 18002 |
| 2025-08-14 | ZYXI | 1.58 | 0.01 | 1.50 | 18003 |
| 2025-08-15 | ZYXI | 1.515 | 0.01 | 0.00 | 18001 |
| 2025-08-18 | ZYXI | 1.53 | 0.01 | 0.00 | 14978 |
| 2025-08-19 | ZYXI | 1.56 | 0.01 | 0.00 | 15083 |
| 2025-08-20 | ZYXI | 1.56 | 0.01 | 0.00 | 15083 |
| 2025-08-21 | ZYXI | 1.535 | 0.00 | 0.00 | 15784 |
| 2025-08-22 | ZYXI | 1.655 | 0.00 | 0.00 | 15994 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-28 | ZYXI | 2.56 | -600.0 | - | -0.74 |
| 2025-07-29 | ZYXI | 2.48 | -600.0 | - | -0.74 |
| 2025-07-30 | ZYXI | 2.49 | -600.0 | - | -0.74 |
| 2025-07-31 | ZYXI | 2.23 | -600.0 | - | -0.74 |
| 2025-08-01 | ZYXI | 1.26 | -600.0 | - | -0.74 |
| 2025-08-04 | ZYXI | 1.73 | -371.4 | - | -1.36 |
| 2025-08-05 | ZYXI | 1.56 | -371.4 | - | -1.36 |
| 2025-08-06 | ZYXI | 1.55 | -371.4 | - | -1.36 |
| 2025-08-07 | ZYXI | 1.47 | -371.4 | - | -1.36 |
| 2025-08-08 | ZYXI | 1.45 | -371.4 | - | -1.36 |
| 2025-08-11 | ZYXI | 1.41 | -371.4 | - | -1.36 |
| 2025-08-12 | ZYXI | 1.60 | -371.4 | - | -1.36 |
| 2025-08-13 | ZYXI | 1.65 | -371.4 | - | -1.36 |
| 2025-08-14 | ZYXI | 1.59 | -371.4 | - | -1.36 |
| 2025-08-15 | ZYXI | 1.52 | -371.4 | - | -1.36 |
| 2025-08-18 | ZYXI | 1.52 | -371.4 | - | -1.36 |
| 2025-08-19 | ZYXI | 1.56 | -371.4 | - | -1.36 |
| 2025-08-20 | ZYXI | 1.53 | -371.4 | - | -1.36 |
| 2025-08-21 | ZYXI | 1.53 | -371.4 | - | -1.36 |
| 2025-08-22 | ZYXI | 1.65 | -371.4 | - | -1.36 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-28 | ZYXI | -0.16 | -18.17 | 19.73 |
| 2025-07-29 | ZYXI | -0.16 | -18.17 | 19.73 |
| 2025-07-30 | ZYXI | -0.16 | -18.17 | 19.73 |
| 2025-07-31 | ZYXI | -0.16 | -18.17 | 19.73 |
| 2025-08-01 | ZYXI | -0.16 | -18.17 | 19.73 |
| 2025-08-04 | ZYXI | -0.08 | -19.07 | 19.70 |
| 2025-08-05 | ZYXI | -0.08 | -19.07 | 19.70 |
| 2025-08-06 | ZYXI | -0.08 | -19.07 | 19.70 |
| 2025-08-07 | ZYXI | -0.08 | -19.07 | 19.70 |
| 2025-08-08 | ZYXI | -0.08 | -19.07 | 19.70 |
| 2025-08-11 | ZYXI | -0.08 | -19.03 | 19.70 |
| 2025-08-12 | ZYXI | -0.08 | -19.03 | 19.33 |
| 2025-08-13 | ZYXI | -0.08 | -19.03 | 19.33 |
| 2025-08-14 | ZYXI | -0.08 | -19.03 | 19.33 |
| 2025-08-15 | ZYXI | -0.08 | -19.03 | 19.33 |
| 2025-08-18 | ZYXI | -0.08 | -26.02 | 19.33 |
| 2025-08-19 | ZYXI | -0.08 | -26.02 | 19.33 |
| 2025-08-20 | ZYXI | -0.08 | -26.02 | 19.33 |
| 2025-08-21 | ZYXI | -0.08 | -26.02 | 19.33 |
| 2025-08-22 | ZYXI | -0.08 | -26.02 | 19.33 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.19
Avg. EPS Est. Next Quarter
-0.18
Insider Transactions
-0.08
Institutional Transactions
-26.02
Beta
1.05
Average Sales Estimate Current Quarter
22
Average Sales Estimate Next Quarter
23
Fair Value
Quality Score
34
Growth Score
36
Sentiment Score
55
Actual DrawDown %
92.1
Max Drawdown 5-Year %
-93.5
Target Price
4.57
P/E
Forward P/E
PEG
P/S
0.35
P/B
39.88
P/Free Cash Flow
EPS
-0.94
Average EPS Est. Cur. Y
-1.36
EPS Next Y. (Est.)
-0.48
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-19.79
Relative Volume
0.51
Return on Equity vs Sector %
-2297.6
Return on Equity vs Industry %
-2623.9
EPS 1 7Days Diff
-0.6
EPS 1 30Days Diff
-0.62
EBIT Estimation
Zynex, Inc.Sector: Healthcare
Industry: Medical Distribution
Employees: 1000
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy. Further, it develops Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser photoplethysmographic patient monitoring device; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; and fluid monitoring and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
stock quote shares ZYXI – Zynex, Inc. Stock Price stock today
news today ZYXI – Zynex, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ZYXI – Zynex, Inc. yahoo finance google finance
stock history ZYXI – Zynex, Inc. invest stock market
stock prices ZYXI premarket after hours
ticker ZYXI fair value insiders trading